E
Dermata Therapeutics, Inc. DRMA
$5.50 -$0.33-5.66% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Net Income -5.22% -31.86% -57.64% -53.75% -22.16%
Total Depreciation and Amortization -- -- -- -- --
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items -85.32% -89.00% 25.93% 23.06% 20.62%
Change in Net Operating Assets -162.93% 287.25% -45.95% 400.89% 314.60%
Cash from Operations -41.39% -39.24% -74.18% -32.59% 1.62%
Capital Expenditure -- -- -- -- --
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -- -- -- -- --
Cash from Investing -- -- -- -- --
Total Debt Issued -- -- -- -- --
Total Debt Repaid -- -- -- -- --
Issuance of Common Stock 199.89% 347.13% -8.97% 56.66% -23.27%
Repurchase of Common Stock -1,603.04% -96.05% -96.05% 97.74% --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities 127.86% -- -- -- --
Cash from Financing 193.35% 348.25% -9.46% 57.63% -25.13%
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 143.93% 223.62% -457.28% 66.02% -59.48%